CORRECTION: Biomerica Reports Q2 2024 EPS $(0.09) Up From $(0.12) YoY, Revenue $1.6M Up From $1.5M YoY
Portfolio Pulse from Benzinga Newsdesk
Biomerica Inc. reported an improvement in its Q2 2024 earnings per share (EPS) to $(0.09) from $(0.12) year-over-year (YoY). The company also saw a revenue increase to $1.6 million from $1.5 million YoY.
January 16, 2024 | 1:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biomerica Inc. reported a year-over-year improvement in Q2 2024 EPS and a small increase in revenue, indicating potential financial stabilization.
The improvement in EPS, even though still negative, suggests a reduction in losses and may be viewed positively by investors. The increase in revenue, albeit modest, indicates growth which could lead to a positive short term impact on BMRA's stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100